Xintian Pharmaceutical announced that the controlling shareholder Xintian Zhi Pharmaceutical has released part of the share pledge, involving 14.16 million shares, accounting for 20.06% of its shares and 5.80% of the company's total share capital. This release of the pledge did not involve additional financing arrangements. As of the announcement date, the total number of pledged shares after the pledge was lifted was 39.0868 million shares, accounting for 55.37% of the shares held and 16.01% of the company's total share capital. The company stated that the current pledge situation will not affect the company's production, operation and governance. The company will continue to monitor the pledge situation and fulfill its obligation to disclose information.

Xintian Pharmaceutical announced that the controlling shareholder Xintian Zhi Pharmaceutical has released part of the share pledge, involving 14.16 million shares, accounting for 20.06% of its shares and 5.80% of the company's total share capital. This release of the pledge did not involve additional financing arrangements. As of the announcement date, the total number of pledged shares after the pledge was lifted was 39.0868 million shares, accounting for 55.37% of the shares held and 16.01% of the company's total share capital. The company stated that the current pledge situation will not affect the company's production, operation and governance. The company will continue to monitor the pledge situation and fulfill its obligation to disclose information.